Skip to main content
. 2021 Feb 1;103-B(2):234–244. doi: 10.1302/0301-620X.103B2.BJJ-2020-0452.R2

Table I.

Summary of recent clinical studies utilizing bacteriophage therapy.

Study Clinical diagnosis, n Bacteria species Treatment approach Clinical outcome
Fish et al33 Diabetic toe ulcers with S. aureus infected bone and soft tissue (n = 6) S. aureus Topical application of phage solution to ulcer Ulcers healed generally in seven weeks; one patient required 18 weeks of treatment
Fish et al34 Distal phalangeal osteomyelitis (n = 1) S. aureus (MRSA) Phage solution injection into the soft tissue surrounding the distal phalanx Reossification of the distal phalanx within 3 mths; 3 yr follow-up patient still free of osteomyelitis
Ferry et35 Osteomyelitis adjacent to the cement located in the right sacroiliac joint (n = 1) P. aeruginosa Phage solution injection into the cavity in contact with bone every 3 days, totalling 4 administrations; also antibiotic therapy Rapid healing within 14 days with no presence of bacteria
Ferry et al36 PJI of the right hip (n = 1) S. aureus Phage solution injection into the joint; also antibiotic therapy Favourable outcome at 18 mths post-treatment without any clinical signs of persistent infection
Onsea et al37  Severe musculoskeletal (pelvis/femur) infections, osteomyelitis (n = 4) P. aeruginosa;
S. epidermidis;
S. agalactiae;
S. aureus;
E. faecalis
Phage solution delivered through draining system in close contact with infected bone; collagen sponge soaked in phage solution was placed on the infected bone prior to wound closure; phage solution three times per day for 7 to 10 days; also antibiotic therapy With single course of phage therapy, no recurrence of infection in periods ranging from 8 to 16 mths
LaVergne et al38 Traumatic brain injury and craniectomy complicated by postoperative infection (n = 1) A. baumannii Phage solution administered intravenously every 2 hrs for 8 days  No further signs of infection at the craniotomy site
Patey et al39 Pelvic bone infection (n = 1);
Complex fracture of right foot (n = 1);
mandibular fracture, osteosynthesis, and fistulized infection (n = 1);
Femoral fracture under hip prosthesis (n = 1);
Left knee prosthesis infection (n = 1);
Osteomyelitis of the left tibia (n = 1);
Left tibia fracture, followed by reopened bone infection (n = 1)
S. aureus (n = 3);
P. aeruginosa;
S. aureus (MRSA) (n = 3);
Staphylococcus sp.
Phage solution administered preoperatively and via catheter in days following operation (n = 3);
Phage solution administered peroperatively (n = 3);
Surgery, phage therapy with commercial phage suspension; also antibiotic therapy
Complete cure (n = 5);
Initial partial disinfection;
Disappearance of S. aureus
Nir-Paz et al40 Left bicondylar tibial plateau fracture (n = 1) A. baumannii;
K. pneumoniae
Phage solution delivered intravenously over 35 mins and over 5 days; second treatment course was given for an additional 6 days, one week later Graft healing; elimination of subtle chronic bone pain; 8 mth post-treatment follow-up indicated no positive cultures for either bacterial strain
Tkhilaishvili et al41 Right knee peri prosthetic infection and chronic osteomyelitis of the femur (n = 1) P. aeruginosa Phage solution applied locally during surgery followed by additional phage solution every 8 hrs through each of the four drains as a local delivery system for five days; also antibiotic therapy Eradication of infection, and no side effects:
10 mth follow-up visit patient reported no pain in the right knee

A. baumannii, Acinetobacter baumannii; E. faecalis, Enterococcus faecalis; K. pneumoniae, Klebsiella pneumoniae; MRSA, methicillin-resistant Staphylococcus aureus; P. aeruginosa, Pseudomonas aeruginosa; S. agalactiae, Streptococcus agalactiae; S. aureus, Staphylococcus aureus; S. epidermidis, Staphylococcus epidermidis